Clinical Trial Update: A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Avotermin (RN1001) for scar improvement after head and neck nevus excision; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanocytic Nevus
• Scar

Drugs mentioned

• Avotermin (Avotermin)

Snippet

Sponsor: Renovo | Conditions: Nevus, Cicatrix | Phase 2 | Status: UNKNOWN